1型糖尿病发病机制及诊疗新进展

鑫湘 马, 春燕 刘, 盼盼 龚

摘要


糖尿病是威胁成人和儿童健康的重要疾病，目前发病率在全球呈上升增长趋势。由于中国人口基数庞大，患病人数也远超其他国家，其中 1 型糖尿病的患病数量也在逐年增长。论文从流行分布、发病机制、治疗方法三方面对 1 型糖尿病进行简述。

关键词


1 型糖尿；分布特点；发病机制；治疗

全文:

PDF

参考


Xia Ying, Xie Zhiguo, Huang Gan, et al. Incidence and trend of type 1 diabetes and the underlying environmental determinants[J]. Diabetes/metabolism research and reviews,2019,35(1).

Nóvoa Yeray, de La Cuesta Araceli, Caballero Elisabeth,et al. Epidemiology of childhood-onset type 1 diabetes in Gran Canaria (2006–2018)[J]. Endocrinología, Diabetes y Nutrición (English ed.),2020,67(10).

ELENA CARRASCO P, BÁRBARA ANGEL B, ETHEL CODNER, et al. Incidencia de diabetes mellitus tipo 1 en Santiago de Chile: análisis por comunas de la Región Metropolitana en el período 2000-2004 Type 1 diabetes mellitus incidence in Santiago, Chile: Analysis by counties in the period 2000-2004[J]. Revista Médica de Chile,2006.

黄晓燕,陈积雄,郑丕媚,等.2006—2017年与1989—1996年海 南省儿童1型糖尿病发病率的比较[J].广东医学,2018,39(24): 3690-3693.

Jean-François Bach, Lucienne Chatenoud. A historical view from thirty eventful years of immunotherapy in autoimmune diabetes[J]. Seminars in Immunology, 2011,23(3).

郑朝安.1型糖尿病的发病机制[J].国际儿科学杂志,2020(4): 274-278.

Srikanta, S, Ganda, et al. Type I Diabetes in Monozygotic Twins: Chronic Progressive Beta Cell Dysfunction[J]. Annals of Internal Medicine, 1983.

Redondo M J, Rewers M, Yu L, et al. Genetic determination of islet cell autoimmunity in monozygotic twin, dizygotic twin, and non-twin siblings of patients with type 1 diabetes: prospective twin study[J]. BMJ (Clinical research ed.),1999,318(7185).

Richard J Mellanby, Jenny M Phillips, Nicole M. Parish,Anne Cooke. Both central and peripheral tolerance mechanisms play roles in diabetes prevention in NOD-E transgenic mice[J]. Autoimmunity,2008,41(5).

Atkinson M A. Thirty Years of Investigating the Autoimmune Basis for Type 1 Diabetes: Why Can’t We Prevent or Reverse This Disease?[J]. Diabetes, 2005,54(5):1253-1263.

Hermann R, Knip M, Veijola R, et al. Temporal changes in the frequencies of HLA genotypes in patients with Type 1 diabetes--indication of an increased environmental pressure?[J]. Diabetologia, 2003,46(3):420-425.

Gillespie K M, Bain S C, Barnett A H, et al. The rising incidence of childhood type 1 diabetes and reduced contribution of high-risk HLA haplotypes[J]. Lancet, 2004,364(9446):1699-1700.

高琦,孙桂香.环境因素在1型糖尿病免疫学发病机制中的研究 [J].医学综述,2007(19):1491-1492.

Pundziute-Lyckå A, Persson LA, Cedermark G, et al. Diet, growth, and the risk for type 1 diabetes in childhood: a matched case- referent study[J]. Diabetes Care. 2004,27(12):2784-2789.

陶桂香,徐洋.1型糖尿病发病机制

Bergenstal R M, Tamborlane W V, Ahmann A, et al. Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes[J]. New England Journal of Medicine, 2010,26(5):383-384.

何斌斌,周智广.1型糖尿病的免疫治疗[J].中国实用内科杂志,2020,40(1):25-29.

Keymeulen B, Walter M, Mathieu C, et al. Four-year metabolic outcome of a randomised controlled CD3-antibody trial in recent- onset type 1 diabetic patients depends on their age and baseline residual beta cell mass[J]. Diabetologia, 2010,53(4):614-623.

MD Pescovitz, Greenbaum C J, Krause-Steinrauf H, et al. Rituximab, B-lymphocyte depletion, and preservation of beta-cell function[J]. N Engl J Med, 2009,361(22):2143-2152.

Pescovitz MD, Greenbaum CJ, Bundy B, et al. B-lymphocyte depletion with rituximab and β-cell function: two-year results[J]. Diabetes Care, 2014,37(2):453-459.

何斌斌,周智广.1型糖尿病的免疫治疗[J].中国实用内科杂 志,2020,40(1):25-29.

Long SA, Rieck M, Sanda S, et al. Diabetes TrialNet and the Immune Tolerance Network. Rapamycin/IL-2 combination therapy in patients with type 1 diabetes augments Tregs yet transiently impairs β-cell function[J]. Diabetes, 2012,61(9):2340-2348.

Yu A, Snowhite I, Vendrame F, et al. Selective IL-2 responsiveness of regulatory T cells through multiple intrinsic mechanisms supports the use of low-dose IL-2 therapy in type 1 diabetes[J]. Diabetes, 2015,64(6):2172-2183.

Couri CE, Oliveira MC, Stracieri AB, et al. C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus[J]. JAMA, 2009,301(15):1573-1579.




DOI: https://doi.org/10.12346/pmr.v4i3.6700

Refbacks

  • 当前没有refback。